These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34965280)

  • 1. Circulating sLR11 levels predict severity of pulmonary hypertension due to left heart disease.
    Joki Y; Konishi H; Ebinuma H; Takasu K; Minamino T
    PLoS One; 2021; 16(12):e0261753. PubMed ID: 34965280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
    Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiographic predictors of adverse short-term outcomes after heart surgery in patients with mitral regurgitation and pulmonary hypertension.
    Corciova FC; Corciova C; Georgescu CA; Enache M; Anghel D; Bartos O; Tinica G
    Heart Surg Forum; 2012 Jun; 15(3):E127-32. PubMed ID: 22698598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreous fluid and circulating levels of soluble lr11, a novel marker for progression of diabetic retinopathy.
    Shiba T; Bujo H; Takahashi M; Sato Y; Jiang M; Hori Y; Maeno T; Shirai K
    Graefes Arch Clin Exp Ophthalmol; 2013 Dec; 251(12):2689-95. PubMed ID: 23652469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble form of LR11 is highly increased in the vitreous fluids of patients with idiopathic epiretinal membrane.
    Hashimoto R; Jiang M; Shiba T; Hiruta N; Takahashi M; Higashi M; Hori Y; Bujo H; Maeno T
    Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):885-891. PubMed ID: 28102455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension due to left heart disease: diagnostic value of pulmonary artery distensibility.
    Colin GC; Verlynde G; Pouleur AC; Gerber BL; Beauloye C; Kefer J; Coche E; Vachiéry JL; Gevenois PA; Ghaye B
    Eur Radiol; 2020 Nov; 30(11):6204-6212. PubMed ID: 32548647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating soluble form of LR11, a regulator of smooth muscle cell migration, is a novel marker for intima-media thickness of carotid arteries in type 2 diabetes.
    Jin W; Jiang M; Han X; Han X; Murano T; Hiruta N; Ebinuma H; Piao L; Schneider WJ; Bujo H
    Clin Chim Acta; 2016 Jun; 457():137-41. PubMed ID: 27095609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of circulating soluble LR11 on long-term clinical outcomes in patients with coronary artery disease.
    Ogita M; Miyauchi K; Kasai T; Tsuboi S; Wada H; Naito R; Konishi H; Dohi T; Tamura H; Okazaki S; Yanagisawa N; Shimada K; Suwa S; Jiang M; Bujo H; Daida H
    Atherosclerosis; 2016 Jan; 244():216-21. PubMed ID: 26687467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of measuring soluble LR11, a circulating marker of atherosclerosis and HbA1c in familial hypercholesterolemia.
    Nohara A; Kobayashi J; Kawashiri MA; Tada H; Inazu A; Jiang M; Mabuchi H; Bujo H
    Clin Biochem; 2014 Sep; 47(13-14):1326-8. PubMed ID: 24859021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble neprilysin does not correlate with prognosis in pulmonary hypertension.
    Yoshihisa A; Yokokawa T; Misaka T; Oikawa M; Kobayashi A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Takeishi Y
    ESC Heart Fail; 2019 Apr; 6(2):291-296. PubMed ID: 30681298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble LR11 competes with amyloid β in binding to cerebrospinal fluid-high-density lipoprotein.
    Yano K; Hirayama S; Misawa N; Furuta A; Ueno T; Motoi Y; Seino U; Ebinuma H; Ikeuchi T; Schneider WJ; Bujo H; Miida T
    Clin Chim Acta; 2019 Feb; 489():29-34. PubMed ID: 30448281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of the soluble LDL receptor-relative LR11 decrease in overweight individuals with type 2 diabetes upon diet-induced weight loss.
    Berk KA; Vongpromek R; Jiang M; Schneider WJ; Timman R; Verhoeven AJ; Bujo H; Sijbrands EJ; Mulder MT
    Atherosclerosis; 2016 Nov; 254():67-72. PubMed ID: 27697674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating soluble LR11, a differentiation regulator for vascular cells, is increased during pregnancy and exaggerated in patients with pre-eclampsia.
    Ishida H; Jiang M; Ebinuma H; Hiruta N; Schneider WJ; Kinoshita T; Bujo H
    Clin Chim Acta; 2019 Oct; 497():172-177. PubMed ID: 31299181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble LR11 associates with aortic root calcification in asymptomatic treated male patients with familial hypercholesterolemia.
    Vongpromek R; Bos S; Ten Kate GR; Bujo H; Jiang M; Nieman K; Schneider W; Roeters van Lennep JE; Verhoeven AJM; Sijbrands EJG; Mulder MT
    Atherosclerosis; 2017 Oct; 265():299-304. PubMed ID: 28637586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma.
    Fujimura K; Ebinuma H; Fukamachi I; Ohwada C; Kawaguchi T; Shimizu N; Takeuchi M; Sakaida E; Jiang M; Nakaseko C; Bujo H
    Clin Chim Acta; 2014 Mar; 430():48-54. PubMed ID: 24394293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction.
    Vanderpool RR; Saul M; Nouraie M; Gladwin MT; Simon MA
    JAMA Cardiol; 2018 Apr; 3(4):298-306. PubMed ID: 29541759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between B-type natriuretic peptide and invasive haemodynamics in patients with severe aortic valve stenosis.
    Maeder MT; Weber L; Ammann P; Buser M; Ehl NF; Gerhard M; Brenner R; Haager PK; Maisano F; Rickli H
    ESC Heart Fail; 2020 Apr; 7(2):577-587. PubMed ID: 31994357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive and non-invasive determinants of pulmonary hypertension in patients with chronic heart failure.
    Capomolla S; Febo O; Guazzotti G; Gnemmi M; Mortara A; Riccardi G; Caporotondi A; Franchini M; Pinna GD; Maestri R; Cobelli F
    J Heart Lung Transplant; 2000 May; 19(5):426-38. PubMed ID: 10808149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction.
    Fayyaz AU; Edwards WD; Maleszewski JJ; Konik EA; DuBrock HM; Borlaug BA; Frantz RP; Jenkins SM; Redfield MM
    Circulation; 2018 Apr; 137(17):1796-1810. PubMed ID: 29246894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension due to left heart disease: diagnostic and prognostic value of CT in chronic systolic heart failure.
    Colin GC; Gerber BL; de Meester de Ravenstein C; Byl D; Dietz A; Kamga M; Pasquet A; Vancraeynest D; Vanoverschelde JL; D'Hondt AM; Ghaye B; Pouleur AC
    Eur Radiol; 2018 Nov; 28(11):4643-4653. PubMed ID: 29761362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.